![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Granules Eltrombopag](https://www.pharmacompass.com/image/flap/granules-eltrombopag-desktop-headergif-14020.gif)
![Granules Eltrombopag](https://www.pharmacompass.com/image/flap/granules-eltrombopag-mobgif-8016.gif)
01 Dr. Reddy\'s Laboratories (4)
02 Alfred E Tiefenbacher GmbH (8)
03 Pharmathen SA (4)
04 Granules India Limited (4)
05 Actavis Inc (1)
06 Amneal Deutschland GmbH (4)
07 Annora Pharma (2)
08 Apotex Inc (2)
09 Assia Chemical Industries Ltd (4)
10 DelNova Healthcare (6)
11 Hetero Drugs (4)
12 Mirpharm (2)
13 Novartis Pharmaceuticals Australia Pty Limited (16)
14 Novartis Pharmaceuticals Corporation (9)
15 Novartis South Africa (Pty) Ltd (2)
16 Teva Pharmaceutical Industries (3)
01 FCT (2)
02 FOR SUSPENSION;ORAL (4)
03 Film Coated Tablet (12)
04 Immediate Release Tablet (3)
05 Oral Solid Dosage Form (4)
06 Suspension (2)
07 TABLET (4)
08 TABLET; ORAL (4)
09 TABLET;ORAL (17)
10 Tablet (6)
11 Blank (17)
01 DISCN (1)
02 EU Dossier Readiness-Q2 2019 (8)
03 Originator (2)
04 Prescription (4)
05 RX (12)
06 US, EU (3)
07 USA (4)
08 Blank (41)
01 ALVAIZ (4)
02 APO-ELTROMBOPAG (2)
03 ELTROMBOPAG (12)
04 ELTROMBOPAG OLAMINE (2)
05 PROMACTA (5)
06 PROMACTA KIT (2)
07 Promacta (4)
08 Promacta Kit (2)
09 REVOLADE (2)
10 Revolade (16)
11 Revolade 25 mg (1)
12 Revolade 50 mg (1)
13 Blank (22)
01 Australia (16)
02 Canada (4)
03 Germany (8)
04 Greece (4)
05 India (14)
06 Russia (2)
07 South Africa (2)
08 USA (25)